Liver Development, Metabolism, Disease and Cancer 

Suzhou, China  

September 11-15, 2023

Abstract deadline: July 28, 2023


Organized by:

Gen-Sheng Feng, University of California San Diego

Lijian Hui, Shanghai Institute of Biochemistry and Cell Biology, CAS

Klaus Kaestner, University of Pennsylvania

We are pleased to announce the Cold Spring Harbor Asia conference on Liver Development, Metabolism, Disease and Cancer will be held in Suzhou, CHINA, located approximately 60 miles west of Shanghai. The conference will begin at 7:00pm on the evening of Monday, September 11, and will conclude after lunch, Friday, September 15, 2023.

The conference will include eight oral sessions and one poster session covering the latest findings across many topics in liver research from health to diseases, especially mechanistic dissections and immunotherapy of liver cancer. Many short talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference provide ample opportunity for informal interactions.

Major Topics:

1. Liver biology and cell lineage tracing

2. Liver progenitors and iPS cells

3. Liver metabolism and metabolic pathways

4. Alcoholic fatty liver diseases

5. Non-alcoholic fatty liver diseases and NASH

6. New technologies in liver research

7. Mechanisms of hepatocarcinogenesis

8. Immunotherapy of liver cancer

9. Translational and clinical liver studies

Keynote Speakers:
Steven Kliewer, UT Southwestern Medical Center 

Invited Speakers:
Lei Dong, Nanjing University
Miguel Esteban, Guangzhou Institutes of Biomedicine and Health, CAS

Gen-Sheng Feng, University of California, San Diego

Bin Gao, National Institute on Alcohol Abuse Alcoholism, NIH 

Daming Gao, Shanghai Institute of Biochemistry and Cell Biology

Valerie Gouon-Evans, Boston University 

Mathias Heikenwälder, German Cancer Research Center (DKFZ)

Mitchell Ho, National Cancer Institute, NIH 

Lijian Hui, Shanghai Institute of Biochemistry and Cell Biology, CAS

Junfang Ji, Zhejiang University

Klaus Kaestner, University of Pennsylvania

Jingya Li, Shanghai Institute of Materia Medica, CAS

Suthat Liangpunsakul, Indiana University School of Medicine

Jiandie Lin, University of Michigan 

Wajahat Mehal, Yale School of Medicine 

Eli Pikarsky, The Hebrew University of Jerusalem

Robert Schwartz, Cornell Medical Center, NYC

Li Tang, National Center for Protein Sciences, Beijing Institute of Lifeomics

Jan Tchorz, Novartis Institutes for BioMedical Research

Zhigang Tian, University of Science & Technology of China

Ludovic Vallier, Berlin Institute of Health

Cun Wang, Shanghai Cancer Institute, Shanghai Jiao Tong University 

Hongyan Wang, Shanghai Institute of Biochemistry and Cell Biology

Cen Xie, Shanghai Institute of Materia Medica, CAS

Aimin Xu, The University of Hong Kong

Huaqiang Eric Xu, Shanghai Institute of Materia Medica, CAS

Bin Xue, Nanjing Medical University

Lars Zender, University Hospital Tübingen

Ning Zhang, Peking University

Zemin Zhang, Peking University

Dawang Zhou, Xiamen University

Shimei Zhuang, Sun Yat-sen Univeristy

We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract submission deadline to be considered for selection. Selection of material for oral and poster presentation will be made by the meeting organizers. Status (fellow's talk/poster) of abstracts will be informed via email as soon as decisions have been made by the organizers. 

We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of oral or poster presentations by graduate students and postdocs in this conference will be selected for fellowship (USD $100-$500) awards during the meeting. For more details, please visit  

We look forward to seeing you at Suzhou in 2023.


Sponsored by: